Mirapex Buyers Bid For Class Status In Antitrust Case

A group of paying customers has banded together in a newly amended complaint to accuse Boehringer Ingelheim International GmbH of prosecuting a patent it knew to be invalid in order to...

Already a subscriber? Click here to view full article